Found 25 matching trials
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) PHASE3 This study will determine whether participants who receive the vaccine V419...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021) PHASE3 To observe the safety, tolerability and immunogenicity of the administratio...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035) PHASE3 A study to compare safety, tolerability, and immunogenicity of a new formul...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) PHASE3 This is a study to assess the safety, tolerability, and immunogenicity of V...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060) PHASE4 The study will evaluate the immunogenicity of the Diphtheria, Tetanus, Pert...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED) PHASE3 The purpose of the study is to evaluate whether V260 is effective and well ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED) PHASE1 This study will assess the safety and tolerability of RotaTeq™ (V260) in th...
Show More Location
Multiple Locations
Learn More & Join Trial
Developing World Study for RotaTeq™ (V260-015)(COMPLETED) PHASE3 The purpose of the current study is to evaluate whether the vaccine is effe...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) PHASE3 The purpose of this study is to evaluate the safety, tolerability, and immu...
Show More Location
Alabama Clinical Therapeutics ( Site 0159)
Learn More & Join Trial
A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN) PHASE3 This study will evaluate the immunogenicity and safety of the pertussis com...
Show More Location
Multiple Locations
Learn More & Join Trial